Literature DB >> 19706093

Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.

David F McDermott1, Bryan Gammon, Peter J Snijders, Ihunanya Mbata, Beth Phifer, A Howland Hartley, Chyi-Chia Richard Lee, Philip M Murphy, Sam T Hwang.   

Abstract

Epidermodysplasia verruciformis is a rare genodermatosis characterized by abnormal susceptibility to infection with specific human papillomavirus serotypes. Epidermodysplasia verruciformis is a genetically heterogeneous disease, and autosomal recessive and X-linked inheritance patterns have been reported. Nonsense mutations in the genes EVER1 and EVER2 have been identified in over 75% of cases. We present epidermodysplasia verruciformis in a father and a son with typical histologic and clinical findings that occur in the absence of mutations in EVER1 or EVER2. Epidermodysplasia verruciformis in this father/son pair in a nonconsanguinous pedigree is consistent with autosomal dominant inheritance. This is the first report of autosomal dominant transmission of epidermodysplasia verruciformis, providing further evidence of the genetic heterogeneity of epidermodysplasia verruciformis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706093      PMCID: PMC3398466          DOI: 10.1111/j.1525-1470.2008.00853.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  17 in total

1.  The histologic spectrum of epidermodysplasia verruciformis.

Authors:  G J Nuovo; M Ishag
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

Review 2.  Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis.

Authors:  M A Lutzner
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

3.  Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a.

Authors:  R Anadolu; T Oskay; C Erdem; A Boyvat; E Terzi; E Gürgey
Journal:  J Am Acad Dermatol       Date:  2001-08       Impact factor: 11.527

4.  Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.

Authors:  Nicolas Ramoz; Luis-Alfredo Rueda; Bakar Bouadjar; Luz-Stella Montoya; Gérard Orth; Michel Favre
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

5.  Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25.

Authors:  N Ramoz; A Taïeb; L A Rueda; L S Montoya; B Bouadjar; M Favre; G Orth
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

6.  Beethoven, a mouse model for dominant, progressive hearing loss DFNA36.

Authors:  Sarah Vreugde; Alexandra Erven; Corné J Kros; Walter Marcotti; Helmut Fuchs; Kiyoto Kurima; Edward R Wilcox; Thomas B Friedman; Andrew J Griffith; Rudi Balling; Martin Hrabé De Angelis; Karen B Avraham; Karen P Steel
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

7.  Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.

Authors:  Kiyoto Kurima; Linda M Peters; Yandan Yang; Saima Riazuddin; Zubair M Ahmed; Sadaf Naz; Deidre Arnaud; Stacy Drury; Jianhong Mo; Tomoko Makishima; Manju Ghosh; P S N Menon; Dilip Deshmukh; Carole Oddoux; Harry Ostrer; Shaheen Khan; Sheikh Riazuddin; Prescott L Deininger; Lori L Hampton; Susan L Sullivan; James F Battey; Bronya J B Keats; Edward R Wilcox; Thomas B Friedman; Andrew J Griffith
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

8.  Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon.

Authors:  E J Androphy; I Dvoretzky; A E Maluish; H J Wallace; D R Lowy
Journal:  J Am Acad Dermatol       Date:  1984-08       Impact factor: 11.527

9.  Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses.

Authors:  M A Lutzner; C Blanchet-Bardon; G Orth
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

10.  Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis.

Authors:  Genshu Tate; Takao Suzuki; Koji Kishimoto; Toshiyuki Mitsuya
Journal:  J Hum Genet       Date:  2004-03-23       Impact factor: 3.172

View more
  4 in total

Review 1.  Severe viral infections and primary immunodeficiencies.

Authors:  Lesia K Dropulic; Jeffrey I Cohen
Journal:  Clin Infect Dis       Date:  2011-09-29       Impact factor: 9.079

Review 2.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

3.  Efficacy of oral zinc therapy in epidermodysplasia verruciformis with squamous cell carcinoma.

Authors:  Sudhanshu Sharma; Krishna Deb Barman; Rashmi Sarkar; Mukesh Manjhi; Vijay Kumar Garg
Journal:  Indian Dermatol Online J       Date:  2014-01

4.  Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.

Authors:  Rui Yoshida; Toshihiko Kato; Masahiko Kawase; Mariko Honda; Tsuyoshi Mitsuishi
Journal:  BMC Dermatol       Date:  2014-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.